newsfilter
← Latest News
Business Wire·

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

Research expected to advance to ‘Full Study' phase in 2025 NanoVibronix, Inc. (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface